Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.2 USD | -7.56% | +20.22% | +18.92% |
Jun. 07 | Chardan Research Initiates Cognition Therapeutics With Buy Rating, $11 Price Target | MT |
May. 29 | HC Wainwright Starts Cognition Therapeutics With Buy Rating, $10 Price Target | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 95.34M |
---|---|---|---|---|---|
Net income 2024 * | -36M | Net income 2025 * | -50M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.51
x | P/E ratio 2025 * |
-2.31
x | Employees | 27 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.98% |
Latest transcript on Cognition Therapeutics, Inc.
1 day | -7.56% | ||
1 week | +20.22% | ||
Current month | +12.82% | ||
1 month | +12.82% | ||
3 months | +22.22% | ||
6 months | +25.00% | ||
Current year | +18.92% |
Managers | Title | Age | Since |
---|---|---|---|
Lisa Ricciardi
CEO | Chief Executive Officer | 64 | 19-02-28 |
John Doyle
DFI | Director of Finance/CFO | 46 | 23-04-30 |
Paul J. Tiseo
CTO | Chief Tech/Sci/R&D Officer | - | 22-10-10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Ricciardi
CEO | Chief Executive Officer | 64 | 19-02-28 |
Brett Monia
BRD | Director/Board Member | 62 | 20-09-30 |
Ellen Richstone
BRD | Director/Board Member | 72 | 21-10-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-13 | 2.2 | -7.56% | 100,269 |
24-06-12 | 2.38 | +14.98% | 209,946 |
24-06-11 | 2.07 | +4.55% | 113,098 |
24-06-10 | 1.98 | +1.54% | 66,439 |
24-06-07 | 1.95 | +6.56% | 82,716 |
Delayed Quote Nasdaq, June 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.92% | 95.34M | |
+17.73% | 123B | |
+16.88% | 111B | |
-9.04% | 23.63B | |
+4.40% | 22.58B | |
-38.15% | 17.61B | |
-7.75% | 17.6B | |
-15.36% | 17.26B | |
+3.42% | 13.55B | |
+29.63% | 11.34B |
- Stock Market
- Equities
- CGTX Stock